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Objective: In this narrative review, an overview is given of the pros and cons of various crystalloid fluids used for
infusion during initial resuscitation or maintenance phases in adult hospitalized patients. Special emphasis is given
on dose, composition of fluids, presence of buffers (in balanced solutions) and electrolytes, according to recent
literature. We also review the use of hypertonic solutions.
Methods: We extracted relevant clinical literature in English specifically examining patient-oriented outcomes
related to fluid volume and type.
Results: A restrictive fluid therapy prevents complications seen with liberal, large-volume therapy, even though
restrictive fluid loading with crystalloids may not demonstrate large hemodynamic effects in surgical or septic
patients. Hypertonic solutions may serve the purpose of small volume resuscitation but carry the disadvantage of
hypernatremia. Hypotonic solutions are contraindicated in (impending) cerebral edema, whereas hypertonic
solutions are probably more helpful in ameliorating than in preventing this condition and improving outcome.
Balanced solutions offer a better approach for plasma composition than unbalanced ones, and the evidence for
benefits in patient morbidity and mortality is increasing, particularly by helping to prevent acute kidney injury.
Conclusions: Isotonic and hypertonic crystalloid fluids are the fluids of choice for resuscitation from hypovolemia
and shock. The evidence that balanced solutions are superior to unbalanced ones is increasing. Hypertonic saline is
effective in mannitol-refractory intracranial hypertension, whereas hypotonic solutions are contraindicated in this
condition.
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The debate on fluid treatment of the surgical and critically
ill patient is ongoing, partly because of insufficient data,
historical and geographical differences, and poor training
[1-3]. This includes the type and amount of fluids to be
given when a patient is considered to be hypovolemic with
a low plasma volume, or in shock, with a low or normal
plasma volume, and in need of fluids for resuscitation or
subsequent maintenance treatment [2,4,5]. Furthermore,
the composition, presence or absence of buffer (so-called
balanced and unbalanced solutions, respectively) and the
additions of certain electrolyte, such as a potassium, cal-
cium and magnesium, are controversial issues.* Correspondence: a.b.j.groeneveld@erasmusmc.nl
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distribution, and reproduction in any mediumThis review aims to describe the place of various crystal-
loid fluids in the treatment of adult hospitalized patients,
in a narrative manner for educational purposes, leading
through various clinical conditions and considerations by
evaluation of various studies. We first discuss normal fluid
and electrolyte composition of the body, balances and
doses of crystalloid fluids, before embarking upon a dis-
cussion of relative pros and cons, under various circum-
stances, of the variously composed crystalloid solutions
currently available. We will not discuss any experimental
animal-derived nor pediatric data and studies. We end
with a discussion of specific electrolyte repletion.Fluid and electrolyte balance of the body
Table 1 shows the daily fluid balance of a healthy 70 kg
male adult with 45 l of total body water (60% of body
weight) [6]. Daily requirements are 80 to 120 mEqsodium,ntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Table 1 Water balance per 24 hour in a healthy 70 kg
male adult
Intake Output
Liquids 1,400 ml Urine 1,500 ml
Water in food 850 ml Skin 500 ml
Water by oxidation 350 ml Respiratory tract 400 ml
Stool 200 ml
Total 2,600 ml Total 2,600 ml
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30 mEq magnesium. Fluid and electrolyte therapy aims to
correctdeficits, and maintain daily requirements and nor-
mal concentrations in body fluids (Table 2).
In hospitalized or critically ill patients, however, fluid
and electrolyte requirements may be increased following
fever, vomiting, diarrhea, blood/plasma loss (trauma and
surgery) and polyuria. For fever, formulas are available
to estimate insensible losses, which approach 10 ml/kg
per 1°C rise in temperature above 37°C [7]. Careful
analysis of fluid intake and output, as well as estimations
of insensible losses, may then be necessary to correct de-
rangements in fluid status of the patient. This assessment
may also include obtaining a body weight on a daily basis,
although the latter is confounded by food intake. In the
intensive care unit (ICU), obtaining daily weight can be
difficult and, although clinically relevant in several (renal)
patient groups, can be poorly associated with fluid bal-
ances [7].
Assessing hypovolemia is hard in hospitalized patients
and many methods, from simple physical to complex
physiological, have been described. Hypovolemia is often,
rightfully or erroneously, considered in case of hypo-
tension, low filling pressures, low central or mixed venous
hemoglobin oxygen saturation, or need of isotropic or
vasopressor drugs, which are clinical triggers for fluid infu-
sion, even though this may benefit the patient only in the
presence of preload and fluidresponsiveness, irrespective of
circulating plasma volume. Fluid responsiveness is defined
by an increase in stroke volume or cardiac output by a fluid
challenge or, preferably, passive leg raising to increase
venous return. Incorporation of this strategy into decisionTable 2 Composition of bodily fluids
Na+ (mmol/l) K+ (mmol/l) Ca2+ (mmol/l) Mg2+ (mmol/l) HC
Plasma 142 4 5 2 101
Plasma
water
153 4.3 5.4 2.2 109
Interstitial
water
139 4 5 2 114
Intracellular
water
10 160 2 26 3making on fluid loading, even in a patient in shock, may
help to prevent potentially harmful overhydration.
Although not beyond doubt, severe hypovolemia may
include the interstitial and eventually even the intracel-
lular space, and repletion of these volumes can be ac-
complished by intravenous fluid administration [8,9].
Hypovolemia and decreased organ perfusion leading to
tissue hypoxia may lead to shock. Fluid losses otherwise
always include plasma water constituents, including so-
dium, potassium and magnesium, and their anions, such
as chloride and bicarbonate, and other electrolytes. Elec-
trolyte losses thus accompany fluid losses, for instance
perioperatively [8]. In addition, the postoperative state is
characterized by non-osmotic release of vasopressin, and
activation of the renin-angiotensin-aldosterone system
and the hypothalamic-pituitary-adrenal axis, with release
of hormones which promote renal retention of water
and sodium, to compensate in part for extrarenal losses.
Repletion of lost plasma should ultimately include all
components, to prevent electrolyte and acid–base de-
rangements, even independently of hypovolemia- and
shock-induced alterations in production and elimination
of acids and shifts in electrolyte distributions between
intra- and extravascular spaces. One should take into ac-
count the electrolyte status of a patient before choosing
an optimal fluid type for resuscitation and maintaining
euvolemia.
Treating hypovolemia and shock
In this section, we will discuss fluid doses and types from
a ‘crystalloid’ perspective. Crystalloid fluid loading may de-
crease mortality in hypovolemic patients, for instance after
hemorrhage [10], but the optimal type and dose of crystal-
loid fluids remains to be defined in a variety of clinical
settings.
In contrast to crystalloids, colloids remain in the circula-
tion and increase intravascular volume by raising colloid
osmotic pressure. They therefore have a three- to fourfold
greater (sustained) plasma volume expanding and hemo-
dynamic effects compared to crystalloids, for a given
infusion volume [5,11-16]. A ratio of 1:3 to 1:4 for colloids







27 2 1 6 16
29 2.2 1 6.5 17
31 2 1 7 1
10 100 20 65
Table 3 Pros and cons of (unbalanced) crystalloid fluids
leading to under- or over-resuscitation in clinical practice
Too little Too much
Tissue hypoxygenation Tissue edema and hypoxygenation




Hyperchloremic metabolic acidosis and
risk forhypernatremia
Gastrointestinal disturbances Anastomotic leakage; diarrhea and other
gastrointestinal disturbances
Pulmonary edema; hepatic congestion
and injury
Prolonged mechanical ventilation
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where increased permeability may limit intravascular
retention of colloid substances, provided that similar
hemodynamic endpoints associated with plasma volume
expansion are reached [11,13,17-20]. Authors have sug-
gested, however, that in daily practice only 10 to 40% more
crystalloids than colloids are infused, and results in similar
resuscitation goals and outcomes [4,6,21-26]. Hence, the
three to fourfold increased requirements for crystalloids
to replace a given plasma volume are probably somewhat
overestimated in clinical practice and are likely to be less.
In hemorrhaged volunteers, 100 to 200% of Ringer’s acet-
ate may suffice to replace lost blood [27]. However, in
other studies only 20% of infusion volumes of crystalloids
are retained intravascularly and more than 60% equili-
brates with the extravascular space within minutes or is
excreted by the kidney within hours after administration
[13,15,28]. Albumin only saves about 40% of saline volume
loading in the so-called SAFE study (a large Australian
study to investigate safety of albumin solution in intensive
care), together with a slightly higher central venous and
arterial blood pressure, and lower heart rate [21].
Indeed, it is likely that the simpler the hemodynamic
targets are, like static hydrostatic pressures, the less they
reflect plasma volume, and the less strictly they are used
to guide resuscitation, the lower is the anticipated vol-
ume difference between resuscitation fluid types [25].
This largely explains some of the seeming discrepancies
noted above and, conversely, implies that the hemo-
dynamic effects of crystalloids are much less than of
roughly equal amounts of infused colloids. Otherwise,
the greater the hypovolemia, the slower the clearance
and longer the half life are of a given infused crystalloid
fluid volume, as calculated from kinetics of hemoglobin
concentrations [29]. Finally, accommodation by unstressed
volume in compliant veins attenuates the plasma volume
expanding effect of infusion fluids.
Although fluid therapy is essential in the treatment of
shock and tissue hypoperfusion, overhydration and
grossly positive fluid balances are, generally, considered
harmful by contributing to organ dysfunction after sep-
sis, trauma or surgery, raising the question which fluid
type and dose can optimize hemodynamics and volume
status, with the lowest risk of fluid overloading [30-34].
Crystalloids do not seem inferior to colloids, that is in-
crease mortality, in surgical and critically ill patients
with hypovolemia or shock of various origins [5,11-16].
Some of excessively infused crystalloid fluids may be ex-
creted by the kidneys, sometimes even more than colloid
fluids, and thereby contribute to limit an increasing fluid
balance over hours and days [15]. It is, however, also
generally suggested that resuscitation with crystalloids
results in a more positive fluid balance and risk for (pul-
monary) edema formation than that with colloids, eventhough the magnitude of this effect has probably also
been overemphasized in the past [17,24-26,30].
The propensity of crystalloid fluids to increase pulmon-
ary edema formation, even in face of increased pulmonary
vascular permeability and edema (in sepsis) at baseline,
has not been confirmed, provided that fluid loading was
done in the steep (rather than the plateau) portion of car-
diac and pulmonary vascular filling [35]. The tendency for
pulmonary edema formation, as inferred from radiologic
and gas exchange changes in other studies, can thus be
explained in part by fluid loading in the plateau of cardiac
filling (fluid unresponsiveness) and pulmonary vascular
filling (pulmonary congestion), independent of fluid type
[17,35]. During hypothermia after cardiac arrest, more iso-
tonic crystalloids were needed as compared to starch and
hypertonic saline, but this did not lead to cerebral edema
[36]. Nevertheless, it cannot be denied that overzealous
crystalloid fluid loading has somewhat greater tendency
for development of peripheral edema (and compartment
syndromes) than resuscitation with colloids, against simi-
lar hemodynamic targets, particularly after multiple
trauma, and that this can be detrimental [16,34,37,38].
Table 3 summarizes the pros and cons of clinical use of
(balanced or unbalanced) crystalloid fluids, related to fluid
volumes.
Compared to isotonic crystalloids, relatively small vol-
umes of hypertonigc solutions may suffice in restoring
euvolemia and hemodynamics without grossly expanding
the interstitial space, in hypovolemia and shock [9,13,30].
Relatively small-volume hypertonic saline 3 to 7% (whe-
ther or not accompanied by colloid fluids) is commonly
used in emergency medicine for patients with traumatic
hemorrhage and/or severe traumatic brain injury [39-42].
Hypertonic solutions may require less volumes than
isotonic crystalloids in maintaining hemodynamics, also
perioperatively, but may not carry other advantages in that
setting [43]. This type of solution exerts a rapid volume
expanding effect, which is larger than that of isotonic solu-
tions, and a positive inotropic effect without too much
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lays or ameliorates a detrimental increase in intracranial
pressure [40]. By limiting volume needs, it may also pre-
vent development of abdominal compartment syndrome,
as compared to Ringer’s lactate during resuscitation from
burn injury [37]. The hypertonic solutions may also have
anti-inflammatory properties [44,45]. Nevertheless, the
formal large-scale clinical studies on the subject are incon-
clusive, as their use may not decrease morbidity or mor-
tality [39-43].
Hypertonic lactate solutions are also available and, like
other hypertonic solutions, may have positive inotropic
effects on the heart [37,46]. Hypertonic saline 3 to 7% can
also be regarded as osmotherapy when applied for re-
ducing intracranial pressure, as a primary drug or when
mannitol has failed, which is the more common applica-
tion [40,47,48]. However, serum sodium levels above 160
mmol/lare unlikely to further decrease cerebral edema
[47]. The treatment may be even more effective in con-
trolling intracranial hypertension than mannitol, but may
not improve outcomes [40,48]. Obviously, the major
adverse effect is severe hypernatremia, which is sometimes
hard to control. Conversely, hypotonic fluids should be
avoided in the condition, carrying the risk of edema ag-
gravation, whereas under-resuscitation and resultant
hypotension are also associated with a worse outcome.
Management thus requires a careful balance, helped by
hemodynamic and intracranial pressure monitoring, be-
tween systemic hemodynamics and cerebral perfusion
pressure.
Perioperative fluid therapy strategies: dose and targets
Dosing and guiding emergency or perioperative crystalloid
fluid therapy is still surrounded by controversy. In spite of
the less plasma volume expanding and hemodynamic
effects of crystalloids versus colloids, for a given fluid infu-
sion volume, a restricted (usually defined as <7 ml/kg/h)
fluid policy has been suggested to result in less complica-
tions than a standard or more liberal fluid strategy, regard-
less of the principal type of solution used, in randomized
studies in surgical patients [30,33,49-55]. The surgery may
involve abdominal, pancreatic, colorectal, gall bladder,
vascular, and hip and knee surgery, whereas definitions of
policies for fluid amounts differ across studies [49-57].
The complications prevented may include anastomotic
leaks, gastrointestinal disturbances with nausea and vomi-
ting, infections, pulmonary complications, and others
[53,56,58]. Indeed, many of these complications may result
from overhydration, particularly by crystalloids, whereas
fluid restriction often refers to limitation of crystalloids
[22,30,49,57,59].
However, too restrictive fluid therapy may result in
under-resuscitation and potentially associated adverse
sequelae, again including gastrointestinal hypoperfusion,anastomotic leaks, nausea, vomiting, and others, which
can be prevented in part by more liberal (colloid or crys-
talloid) fluid loading [30,54,59-63]. Perioperative, goal-
directed hemodynamic optimization by (mostly colloid,
sometimes crystalloid) fluids may better reduce postop-
erative complications, because of dosing fluids to in-
dividual needs in the patient and by taking individual
cardiac reserve into account, than either liberal or re-
strictive policies [2,4,22,52,53,61,64-66].
Hence, the debate on fluid volumes and hemodynamic
targets is confounded by the type of fluid, with increas-
ing doubts on the safety of synthetic colloids, at least in
sepsis and perhaps not in trauma and surgery, thereby
favoring crystalloids [25,67]. Also, the risk to benefit
ratio of a fluid type may be determined by the severity of
hypovolemia and shock during which it is infused. In
any case, preoperative starvation commonly includes
fluids and may contribute to postoperative hypovolemia
[68], and authors have studied the effect of preoperative
optimization with help of Ringer’s lactate and found that
this policy reduced postoperative morbidity [69]. In the
emergency treatment of trauma, avoidance of overzea-
lous crystalloid fluid therapy may also be associated with
better outcomes [34].
Concluding this section, one should give crystalloid
fluid challenges as a first choice on clinical grounds, for
resuscitation from hypovolemia or shock, by utilizing
rapid infusions of 500 to 1000 ml, provided that the pa-
tient is likely to be fluid responsive at baseline or indeed
responds to fluids during loading. In the maintenance
phase, measurable losses augmented by 1 l per day for
insensible losses mostly result in infusion of about 2 to
2.5 l per day. For resuscitation and maintenance, special
considerations obviously apply to brain injury, trauma
and surgery, when restriction of fluids and electrolytes
may be preferred to limit a positive fluid balance, and to
cardiac failure and edema-forming states, when a nega-
tive fluid balance rather than maintaining the balance is
aimed at.
Composition and clinical use of various crystalloid fluids
We will now discuss varying crystalloid fluid types and
their properties. Normal or physiological saline was first
described and applied in 1831, and since then 0.9% so-
dium chloride (NaCl) is the most widely used intravenous
fluid in the hospital, in spite of doubts on its ‘normal’ or
‘physiological’ properties [70]. Adding lactate as a buffer
to better resemble electrolyte composition of human
plasma yields Ringer’s lactated (or Hartmann’s) solution,
yet is still slightly hypotonic with the ability to lower
serum osmolality [71]. Hypotonic solutions, including
colloids (albumin) and crystalloids, may increase (the risk
for) cerebral edema in traumatic brain injury, which seems
determined in part by osmotic pressure, unless rapid
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[71,72]. Infusion of hypotonic dextrose 5% in water is thus
also contraindicated in traumatic brain injury, if decreas-
ing plasma osmolality [11]. The solution has a minimum
effect on plasma volume and is therefore not a suitable
resuscitation fluid either. Therefore, normal saline or
isotonic balanced solutions should be preferred to treat
hypovolemia in brain injury. Sodium bicarbonate is avail-
able in hypertonic solutions. Even though the benefit of
treating metabolic (lactic) acidosis during ischemia and
resuscitation is controversial, sodium bicarbonate is still
widely used to ameliorate metabolic acidosis from various
other origins and adjunctive treatment to keep the pH
above 7.15 to 7.20 in high risk patients remains commonly
recommended. Sodium bicarbonate is also used in the
prevention of contrast nephropathy, although probably
hardly more effective than prehydration with normal sa-
line [73-75]. Conversely, infusion may not be harmless,
and result in hypernatremia and overshoot alkalosis if (too
much of) hypertonic solutions are used.
Commonly applied crystalloid solutions of osmolality,
cationic and anionic composition are described in Table 4.
Chloride and balanced solutions
The chloride content of normal saline (0.9% NaCl), a so-
called unbalanced solution, that is 154 mmol/l, is much
higher than found in plasma (101 to 110 mmol/l) and
higher than the so-called balanced solutions as (modi-
fied) Ringer’s or Hartmann’s, where some of the anions
are buffering lactate, acetate, or gluconate instead of
chloride [76]. The strong ion difference of these latter
solutions is thus higher than that of saline (for example
closer to that of plasma, 42 mEq/l). Even though the pH
of these solutions may not differ much, their in vivoTable 4 Commonly applied crystalloid solutions: osmolality, c
Osmolality
(mOsm/kg)
pH Na+ (mmol/l) K+ (mmol/l) Ca2+ (mm
0.9% saline 308 5.5 154
Ringer’s 309 147 4 5
Ringer’s lactate 273 6.5 130 5.4 2.7
Ringer’s lactate 273 6.5 130 5.4 2.7
Hartmann’s 280 6.5 131 5.4 2
Modified 290 145 4 2.5
Balanced 294 5.5 140 5
Fluids 299 5.5 140 10 5
1.4% Na bicarbonate 333 >7.0 167
4.2% Na bicarbonate 1,000 >7.0 500
8.4% Na bicarbonate 2,000 >7.0 1,000
3% saline 1,026 513
7% saline 2,394 1,197
aacetate, a1 with 5 mmol/l maleate,
b27 mmol/l as acetate and 23 mmol/l as gluconaeffects on acid–base balance are profoundly different [77].
Indeed, saline infusion commonly leads to hyperchloremic
metabolic acidosis and contributing to hyperkalemia, par-
ticularly when large volumes are infused, whereas infusion
of balanced solutions does not carry this effect [76,78-86].
Although the use of saline may result in organ dys-
function (shown extensively in animal studies) and may
contribute to gastrointestinal symptoms after surgery,
the true detriments of hyperchloremic acidosis in clin-
ical studies remain uncertain [76]. Furthermore, plasma
dilution, by any type of infusion solution not containing
bicarbonate (or precursor buffer anions), including dex-
trose 5% in water, decreases strong ion differences and
thus blood pH [87].
However, Shaw et al., in a large retrospective study,
using propensity-matched samples, recently found that
use of normal saline resulted in a higher mortality than
using balanced solutions during and following surgery
(5.6% versus 2.9%), preventing hyperchloremic metabolic
acidosis as well [88]. In addition, the administration of bal-
anced solutions was associated with less morbidity as
shown by fewer days on the ventilator, less need for fluid,
less need for transfusions, fewer major infections and less
need for renal replacement therapy. This suggests that
balanced solutions are favored to saline considering the
risk of metabolic derangements as hyperchloremic meta-
bolic acidosis and patient morbidity, and clinical course.
However, the mechanisms of some of these effects in
humans remain unclear and further research on effect on
morbidity and mortality is needed [76,89].
Finally, we caution against the use of potassium-
containing balanced solutions in anuric patients with
renal insufficiency since the infused potassium cannot
be excreted ultimately.ationic and anionic composition
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Hepatic uptake results in gluconeogenesis, an energy cost-
ing process. Oxidation is the fate of 30 to 60% of infused
lactate, even in septic and cardiogenic shock, thereby
sparing other substrates [90]. Lactate may thus serve as a
fuel for liver, and even heart and brain, particularly when
other substrates are less available [46]. Infusion of (large
quantities of) lactate-containing infusions may transiently
and slightly elevate the serum lactate level (but do not
decrease pH), particularly in case of liver dysfunction
[46,91,92]. It may increase glucose levels in patients with
poorly controlled diabetes mellitus or otherwise enhanced
gluconeogenesis. Use of Ringer’s lactate is safer and saves
more lives than use of starch solutions, when compared in
the resuscitation of septic shock [67].
Ringer’s acetate solution closely resembles Ringer’s lac-
tate. Acetate, a component of Ringer’s acetate and other
solutions, is, similarly to lactate, not metabolically inert.
It enters the tricarboxylic acid cycle and is combusted,
thereby consuming oxygen by partly replacing other
substrates. Indeed, when infused, about 90% is oxidized.
Acetate as a buffer, so that, upon infusion, the bicarbon-
ate concentration and pH rises, similarly as when
equimolar bicarbonate is infused, in acidosis following
diarrhea or renal insufficiency [93]. Also, acetate carries
vasodilating and myocardial depressant properties, and
may thus be harmful in patients with shock [94], al-
though this has been denied in other studies [95,96]. In
fact, it has recently been demonstrated that resuscitation
from septic shock with Ringer’s acetate results in greater
survival than resuscitation with colloid, but this can be
attributed to adverse effects of starches [25].
Renal effects
On the one hand, crystalloid solutions better preserve
diuresis and renal function, and prevent need for renal
replacement therapy than colloids in the critically ill
[24], but not in healthy volunteers [15], probably by a
fall in plasma colloid osmotic pressure promoting glom-
erular filtration. However, crystalloid fluid overloading
per se may be associated with increased need for renal
replacement therapy [16,76].
Recent evidence suggests that this may also depend
on the type of crystalloid administered and the evidence
for a renal protective effect of balanced (versus unba-
lanced) crystalloids is cumulating. Hypotonic Ringer’s
lactate infusion in healthy volunteers is more rapidly ex-
creted via urine than normal saline (requiring hours),
but this can be attributed in part to hypotonicity of the
fluid rather than prevention of hyperchloremia, even
though normochloremia may protect against a fall in
measured renal (and gastric) blood flow associated with
hyperchloremia [76,81,83,97]. Animal experiments in-
deed suggest that hyperchloremia may increase renalvascular resistance and decrease blood flow following a
direct renal vasoconstrictive effect by the chloride anion.
Hadimioglu et al. compared in a randomized controlled
trial balanced fluids with normal saline as intraoperative
fluid replacement during renal transplant surgery, and
showed that only saline decreased pH, bicarbonate and
base excess [92]. This and other studies did not demon-
strate a difference in the effects on renal function, but
these studies may have been underpowered [84,92].
In contrast, a recent large sequential cohort study sug-
gests that the use of a chloride-restricted fluid regimen
of (modified) Ringer’s lactate solution (versus chloride
liberal and saline-based regimens) did not decrease mor-
tality, but decreased acute kidney injury and need for
renal replacement therapy [98]. In the study by Shaw
et al., mentioned above [88], administration of balanced
solutions is associated with a reduction of need of renal
replacement therapy after laparotomy from 4.8 to 1.0%
(P<0.001), even after adjustment for confounders. The
incidence of tubular injury and acute kidney injury in
sodiumbicarbonate-treated cardiac surgery patients may
be lower than when equimolar saline is used [99,100].
However, the implications for hospitalized patients with
risk factors for renal dysfunction still need to be firmly
established.
Immune depression and coagulation
Another controversy relates to alleged immune effects
of balanced versus unbalanced solutions [76]. It has
been suggested that normal, unbalanced saline has
proinflammatory properties, relating to neutrophil acti-
vation [44,101]. This may contribute to detrimental ef-
fects in trauma and sepsis resuscitation. Ringer’s lactate
may also be proinflammatory but it appeared that the
D-lactate in racemic mixtures was largely responsible,
so that its elimination abolished that effect [101,102].
Hypertonic saline has been claimed to have anti-
inflammatory properties, but this is not beyond doubt
either [101]. In contrast, the chloride anion has been
suggested to impair coagulation [76,81]. However, saline
and Ringer’s lactate (−based colloid solutions) equally
induced, ex vivo, a hypercoagulable state at 20 to 40%
dilution of blood and decreased coagulability at 60% di-
lution [103,104].
Electrolyte solutions to treat electrolyte disorders
In hospitalized and surgical or critically ill patients, elec-
trolyte disturbances are common [8,105]. Solutions are
available to selectively supplement specific electrolyte
deficits. Hypokalemic alkalosis is common and risk fac-
tors include use of diuretics, vomiting and diarrhea, and
others, leading to chloride depletion. The condition may
be accompanied by hypomagnesemia and may be a risk
factor for cardiac depression, tissue hypoxygenation and
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more successful by potassium supplementation when
hypomagnesemia is simultaneously corrected. Potassium
repletion can be accomplished by the oral and enteral
route, if functioning, or otherwise by slow, intravenous
administration of concentrated solutions at a maximum
rate of 20 mEq/h, or higher if vitally indicated [106,107].
Infusion of potassium-containing balanced solutions may
lead to dangerous hyperkalemia in the patient with renal
insufficiency and anuria who cannot excrete the extra po-
tassium load, although, on the other hand, prevention of
acidosis may somewhat ameliorate a dangerous increase
in serum potassium concentration [84,86,92,106].
Dysnatremia is often observed in the ICU setting and is
associated with higher in-hospital mortality. Hypertonic
saline is used in the urgent treatment, when indicated, of
hyponatremia [108,109]. Glucose 5% is commonly used in
the treatment of hypernatremia. For maintenance fluid
therapy in the starving patient, the more complete and
balanced solutions are more likely to maintain normal
plasma electrolyte concentrations and acid–base balance
than merely sodium-containing saline. To these fluids that
resemble plasma but are not identical as far as their com-
position is concerned, glucose 5% can be added to meet
some energy requirements too.
Hypocalcemia is also relatively frequent in postoperative
and critically ill patients and may have adverse conse-
quences [110]. It is likely that most critically ill patients
are in a negative calcium balance, when immobilized,
treated by citrate-based venovenous hemofiltration for
acute kidney injury, and so on. A calcium deficit may lead
to gradual bone loss. Hypocalcemia, even when adjusted
for hypoalbuminemia, and resulting from a shift of extra-
to intracellular calcium and hypovitaminosis D, may be
associated with critical illness neuro- and myopathy [111].
Calcium is hard to include in (alkali) fluids, because it
may easily become insoluble.
Continuous renal replacement therapy is a well
known risk factor of hypophosphatemia in the critically
ill. The latter may also be a feature of refeeding and
hypophosphatemia is thus relatively frequently encoun-
tered in the critically ill patient (with and without renal
failure) [111]. It may be associated with muscle weak-
ness and prolonged need for mechanical ventilator
support, and therefore requires prevention and correc-
tion with help of sodium-potassium-phosphate solu-
tions, preferably via continuous infusions [112,113].
Currently, phosphate containing replacement fluids are
available to prevent hypophosphatemia during continu-
ous renal replacement therapy.
Conclusion
Crystalloid fluids are the fluids of choice for expanding
and maintaining plasma volume in hospitalized patientswith hypovolemia or shock, although relatively large
volumes have to be administered to increase circulating
plasma volume and tissue oxygen delivery. Overzealous
crystalloid administration increases the risk for fluid
overload with hypernatremia, peripheral and pulmonary
edema, and compartment syndromes. Hence, both under-
resuscitation and overhydration should be avoided by
careful monitoring. The evidence that balanced solutions
are superior, particularly in helping to prevent acute
kidney injury and when isotonic, to unbalanced ones is
increasing. Hypotonic solutions are generally contraindi-
cated in conditions with or at risk for cerebral edema.
In the maintenance phase of non-oral fluid infusion, so-
lutions which more resemble plasma water composition
than normal saline are also to be recommended. We finally
recommend serum sodium-guided treatment by hypertonic
saline for mannitol-refractory cerebral edema and intra-
cranial hypertension.
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